semaglutide news today 2025 Drug Watch: The oral version of is now approved for weight reduction, with a maintenance dose of 25 mg daily. "For patients paying for the oral option out of pocket, the Scientists find Ozempic may treat

At the same time, prefrontal cortical regions responsible for impulse control and long-term planning lose regulatory influence, weakening an individuals capacity to resist cravings or evaluate consequences

Food and Drug Administration (FDA) approval for the treatment of type 2 diabetes (Mounjaro ) and for chronic weight management (Zepbound )

Microbial metabolites and brain signaling Beyond GLP-1 itself, the metabolites produced by the three Pendulum strains have independent effects on brain-gut communication

Sci Adv 2022;8:eabn5345.ArticlePubMedPMC 72

Early side effects like nausea & vomiting are temporary Nausea is a common side effect of semaglutide, but this is not true for every patient

In conclusion, it seems that GLP-1/exendin-4 acts in the VMH and LH, modulating the activation status of AMPK and S6K1 in response to glucose fluctuations, helping to improve pathophysiological states such as obesity and insulin resistance